Filter
2304
Filtered Results: 2304
Text search:
controlled
drugs
Featured
Recommendations
264
New Publications
513
Language
Document type
No document type
1341
Guidelines
400
Studies & Reports
312
Manuals
117
Strategic & Response Plan
62
Fact sheets
32
Training Material
26
Situation Updates
6
Brochures
4
Resource Platforms
2
Infographics
2
Countries / Regions
India
171
Kenya
65
Global
63
South Africa
56
Western and Central Europe
46
Uganda
43
Ethiopia
40
Nigeria
38
Tanzania
34
Sierra Leone
33
Latin America and the Carribbean
32
Africa
31
Zambia
30
Nepal
29
Malawi
28
Ukraine
28
Ghana
26
Eastern Europe
26
Liberia
23
Rwanda
23
Philippines
22
Myanmar / Burma
22
Zimbabwe
20
Bangladesh
19
Colombia
17
Russia
17
Brazil
16
Syria
15
Indonesia
15
South–East Asia Region
15
Lesotho
14
Asia
13
South Sudan
12
Mozambique
11
Namibia
11
Eswatini/ Swaziland
11
Burkina Faso
10
Senegal
9
Argentina
9
Congo, Democratic Republic of
8
Botswana
8
Guinea
7
Cameroon
7
Germany
7
East and Southern Africa
7
Paraguay
7
Venezuela
7
Afghanistan
6
Yemen
6
Haiti
5
Lebanon
5
Thailand
5
Sudan
5
Bolivia
5
Eastern Europe and Central Asia
5
Tajikistan
5
Mali
4
USA
4
Iraq
4
Jordan
4
Chile
4
West and Central Africa
4
Middle East and North Africa
4
North America
4
Somalia
3
Pakistan
3
Cambodia
3
Central African Republic
3
Peru
3
Angola
3
Madagascar
3
Moldova
3
Iran
3
Georgia
3
Guinea-Bissau
2
Morocco
2
Saudi Arabia
2
Egypt
2
China
2
Benin
2
North Macedonia
2
Hungary
2
Ecuador
2
Libya
2
Mexico
2
Bhutan
2
Palestine
2
Albania
2
Laos
2
Canada
2
Lithuania
2
Kyrgyzstan
2
Vietnam
2
Jamaica
2
Côte d’Ivoire / Ivory Coast
1
Turkey
1
Singapore
1
Papua New Guinea
1
Serbia
1
Burundi
1
Greece
1
Sri Lanka
1
Western Pacific Region
1
Poland
1
Djibouti
1
Armenia
1
Timor Leste/ East Timor
1
Qatar
1
Romania
1
Australia
1
Kazakhstan
1
Gabon
1
Turkmenistan
1
Denmark
1
Mauritius
1
Tunisia
1
United Kingdom
1
Norway
1
Portugal
1
Azerbaijan
1
Authors & Publishers
Publication Years
Category
Countries
819
Clinical Guidelines
321
Public Health
156
Women & Child Health
105
Key Resources
55
Pharmacy & Technologies
29
Capacity Building
26
Protection & Security
1
Toolboxes
Mental Health
292
HIV
222
TB
205
COVID-19
113
AMR
90
Pharmacy
88
NCDs
87
NTDs
67
Caregiver
57
Rapid Response
49
Ebola
45
Conflict
35
Refugee
26
Disability
22
Planetary Health
21
Cholera
14
Global Health Education
14
Natural Hazards
13
Polio
10
Specific Hazards
6
Health Financing Toolbox
6
Zika
5
Social Ethics
2
Not long ago, on the occasion of the 100th anniversary of the discovery of Chagas disease, several campaigns denounced the scant progress has been made in diffrent spheres- medical, scientific and politcal- but major challanges still remain. This is an appropriate time to celebrate what has been ach...
Over 6 million people worldwide are infected with Trypanosoma cruzi, the protozoan that causes Chagas disease
(CD). T. cruzi is transmitted by triatomine insects, congenitally, through uncontrolled blood donations and organ transplants,
and via consumption of food or drink contaminated by triatomi...
Report of the WHO/Bill & Melinda Gates Foundation Consultation. The Consultation was organized back-to-back with the first annual meeting of the International Coordinating Group of the BMGF-funded project for human and dog rabies elimination in developing countries, held at WHO headquarters, Geneva,...
This chapter discusses the antibacterial treatment of leprosy infections. Antibiotic treatment is
a key component of leprosy treatment, as it is vital to prevent the progression of the infection.
Treatment with rifampin and other antibiotics is highly effective and cures 98% of patients with
the ...
Female Genital Schistosomiasis (FGS) is a gynaecological disease caused by Schistosoma haematobium, a parasitic worm that is acquired by skin contact with freshwater contaminated by schistosome cerceriae. Communities in which the infection is most endemic have limited access to clean water and healt...
A wide spectrum of disease severity has been described for Human African Trypanosomiasis (HAT) due to
Trypanosoma brucei rhodesiense (T.b. rhodesiense), ranging from chronic disease patterns in southern countries of East Africa to an increase in virulence towards the north. However, only limited d...
Chromoblastomycosis (CBM), represents one of the primary implantation mycoses caused by melanized fungi widely found in nature. It is characterized as a Neglected Tropical Disease (NTD) and mainly affects populations living in poverty with significant morbidity, including stigma and discrimination.
The objectives of the meeting were:
1. To update the current status of the disease transmission, country capacities and plans for tackling the disease.
2. To understand the epidemiology including disease distribution and risk, the models
for estimating under-detection, the geographical variati...
The conditionality of this recommendation is largely driven by the current higher unit cost of pyrethroid-PBO ITNs compared
to pyrethroid-only LLINs and therefore the uncertainty of their cost-effectiveness. Furthermore, as PBO is less wash-resistant
than pyrethroids, its bioavailability declines ...
https://doi.org/10.1371/journal.pntd.0002439
South Sudan has a high burden – among the highest in sub-Saharan Africa – of neglected tropical diseases (NTDs). This adversely affects the health and social and economic well-being of people in the country. The prevention, control and eventual elim...
Adolescence, defined as the period between 10 and 19 years of age, is a developmental stage during which many psychosocial and mental health challenges emerge. There is a well-established link between mental health and HIV outcomes. Adolescents and young adults living with HIV typically have additio...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The burden of diabetes is enormous, positioning it as one of the main challenges facing public health today. Currently, it is estimated that 62 million people are living with diabetes in the Region of the Americas and projections show its prevalence will continue rising over the following years. The...
La carga de la diabetes es enorme, posicionándola como uno de los principales desafíos que enfrenta la salud pública en la actualidad. Actualmente, se estima que 62 millones de personas viven con diabetes en la Región de las Américas y las proyecciones muestran que su prevalencia seguirá aumen...
The World Heart Federation (WHF) is a leading global advocate for stronger legislation and policies regarding cardiovascular disease (CVD) and its risk factors, including raised cholesterol. The present Cholesterol Advocacy Toolkit 2022 provides WHF member organizations with information as well as p...
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector...
The Coronavirus Disease 2019 (COVID-19) has had a continuous and robust impact on world health. The resulting COVID-19 pandemic has had a devastating physical, mental and fiscal impact on the millions of people living with noncommunicable diseases (NCDs), as they have a higher risk of severe illness...
Myocardial infarctions are generally clinically classified into ST elevation MI (STEMI) and non-ST elevation MI (NSTEMI), based on changes in ECG. When blood flow to a part of the heart stops or the heart is injured and fails to receive enough oxygen required for its adequate functioning the conditi...
Cardiovascular diseases (CVDs) have collectively remained the leading causes of death worldwide and substantially contribute to loss of health and excess health system costs. The Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study has tracked trends in death and disability since 1990 a...
Approximately 80% of the 463 million adults worldwide with diabetes live in low-income and middle-income countries (LMICs). A major obstacle to designing evidence-based policies to improve diabetes outcomes in LMICs is the scarce availability of nationally representative data on the current patterns...
